You should be advised to: Report any new neck swelling or changes in voice Monitor for symptoms of thyroid dysfunction (either hypo- or hyperthyroidism) Maintain consistent timing of levothyroxine administration Keep a record of weight changes Report severe or persistent gastrointestinal symptoms Stay well-hydrated, especially if experiencing nausea, vomiting or diarrhoea Medication adherence to both levothyroxine and GLP-1 therapy is essential for optimal outcomes
Some patients achieve their goal weight at 1.0 mg or 1.7 mg and remain there with their providers agreement

Brightens and evens skin tone Reduce pigmentation, dark spots, and hyperpigmentation for a glowing complexion Detoxifies the body Flush out harmful toxins and reduce oxidative stress for better overall health Reduces the appearance of wrinkles and fine lines Promotes collagen production, giving you youthful, radiant skin Improves skin clarity Fight acne, blemishes, and uneven skin texture for a smoother, clearer complexion Boosts immune function Strengthen your bodys natural defenses against illness and inflammation Enhances energy levels Combat fatigue and feel revitalised from within Supports liver health Detoxifies the liver, which in turn helps improve skin and overall wellness Treatment Time: Approximately 45-60 minutes Results: Immediate improvement in hydration and a radiant glow, with noticeable skin clarity and brightness seen after 3 or 4 treatments Lasts: Results can last for up to 12 months, depending on your lifestyle, skin condition, and follow-up treatments Downtime: None You can resume normal activities immediately after treatment Tailored to Your Needs: We offer customised formulations to suit your unique skin goals, ensuring a personalised experience every time

Research shows that weight loss and improved metabolic health can boost confidence, self-image and sexual self-esteem, which for many patients enhances rather than diminishes desire. Dix noted that because GLPs affect the reward areas of the brain, they are believed to reduce compulsive behaviours
These effects were sustained at week 48, with 89% and 93% of participants maintaining hepatic fat levels below the steatosis threshold